·çÁ¨¿¡½º¾¾¾ÆÀÌ´Â °í°´¸¸Á·À» À§ÇØ ÃÖ¼±À» ´ÙÇÒ°ÍÀ» ¾à¼Óµå¸³´Ï´Ù.

We could promise we will do our best trials to meet customers' requests


Á¦¸ñ Protein Foundry¸¦ ¼Ò°³ÇÕ´Ï´Ù.
ÀÛ¼ºÀÚ lugensci
ÀÛ¼ºÀÏÀÚ 2023-07-18

 

#Protein FoundryÇѱ¹°ø½Ä´ë¸®Á¡ ·çÁ¨¿¡½º¾¾¾ÆÀÌ Protein Foundry LLC

Áö³­ 20³â µ¿¾È ´ç»çÀÇ ¿¬±¸ ÇÁ·Î±×·¥Àº ¿ÏÀüÇÑ »ý¹°ÇÐÀû È°¼ºÀ» À§ÇØ Ãµ¿¬ N-¸»´Ü ¾Æ¹Ì³ë»ê ¼­¿­À» º¸Á¸ÇÏ´Â µ¥ ƯÈ÷ ÁÖÀÇÇϸ鼭 ÄɸðÄ«ÀÎÀÇ »ý»ê ¹× ±â´É ºÐ¼®¿¡ ÃÖÀûÈ­µÈ µ¶Æ¯ÇÏ°í Àü¹®È­µÈ ºÐÀÚ µµ±¸¸¦ °³¹ßÇß½À´Ï´Ù.

À§½ºÄܽŠÀÇ°ú´ëÇп¡¼­ °³¹ßµÈ ´É·üÀûÀÌ°í È®Àå °¡´ÉÇÑ ÀçÁ¶ÇÕ »ý»ê ¹æ¹ýÀ» »ç¿ëÇÏ¿© È­ÇÐÀû ¼øµµ, ±¸Á¶Àû ±ÕÁú¼º ¹× ±â´ÉÀû È¿´É Ãø¸é¿¡¼­ ÃÖ°í Ç°ÁúÀÇ ÀçÁ¶ÇÕ ´Ü¹éÁúÀ» °ø±ÞÇϱâ À§ÇØ ÃÖ¼±À» ´ÙÇÏ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ NMR ¶Ç´Â Áú·® ºÐ¼® ÀÀ¿ë ÇÁ·Î±×·¥¿¡ »ç¿ëÇϱâ À§ÇÑ ¾ÈÁ¤ÇÑ µ¿À§¿ø¼Ò¸¦ »ç¿ëÇÑ ´ë»ç ¶óº§¸µÀ» Æ÷ÇÔÇÏ¿© ¸ÂÃãÇü ÄɸðÄ«ÀÎ »ý»ê ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù.



Crystal Structure of CCL21 and Identification of a Sulfotyrosine Binding Site by NMR

Custom-made 15N-enriched CCL21 protein supplied by Protein Foundry The chemokine CCL21 guides both T cell and metastatic cancer homing to lymph nodes by activating the receptor CCR7. CCL21 is among a handful of chemokines with an unstructured
Read More

Protein Foundry¡¯s CXCL4 Used to Identify Antibodies That Cause Heparin-Induced Thrombocytopenia

Cloned antibodies from patients with heparin-induced thrombocytopenia (HIT)  provide new clues to HIT pathogenesis A recent study published in Blood from scientists at @BloodCenterWI and @MayoClinic reveals structural differences between
Read More

Cooperative Chemokine Signaling Influencing T Cell Movement from Blood to Tissue

Chemokine positioning assists extravasation of pathogenic human T cells
Read More

Assays for Measuring Cell Surface __Expression__ of CXCR4

When a chemokine binds to its G protein-coupled receptor one of the consequences of receptor activation is a decrease in the levels of receptor present on the cell surface due to more rapid internalization. The mechanism of GPCR internalization
Read More

CXCL12 potentiates chromatin compaction via ACKR3 activation

CXCL12 and its receptor CXCR4 have well known roles in bone marrow homing and  mobilization of hematopoietic stem cells and neutrophils, but inflammatory neutrophil  recruitment is governed by CXCR2 and its
Read More

Chemokine CXCL4 key to rare COVID-19 vaccine side effect

Chemokine CXCL4 key to rare COVID-19 vaccine side effect
Read More

Human CXCL10 identified as a risk factor for cardiovascular disease

Plasma concentrations of inflammatory proteins can serve as biomarkers for cardiovascular disease (CVD). Previous studies had linked the T cell chemokine CXCL10/IP-10 to hypertension and heart failure, but failed to achieve the statistical significance necessary for its use as a biomarker for human disease.
Read More

Human CXCL4 (PF4) linked to Covid-19 vaccine blood clots

As reported recently in the Wall Street Journal and other publications, the human chemokine CXCL4 (also known as platelet factor 4 or PF4) is the common link between COVID-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) and a more common condition known as heparin-induced thrombocytopenia (HIT).
Read More

Origins of Metamorphism in XCL1

A new TiBS Spotlight features the work of Protein Foundry scientists and collaborators on the evolution of a highly unusual chemokine.
Read More

Study reveals evolutionary origins of fold-switching protein

A shapeshifting immune system protein called XCL1 evolved from a single-shape ancestor hundreds of millions of years ago. Researchers at the Medical College of Wisconsin discovered the molecular basis for how this happened, in  a study
Read More

Modeling ligand-receptor specificity

Using a hybrid modeling approach, Fox generated a model for the chemokine XCL1 in complex with its G protein-coupled receptor XCR1 and identified key interaction sites. Changes within a region of XCL1 that determined its binding energy to XCR1 changed the activity of the receptor and, consequently, cell migration
Read More
´Ù¿î·Îµå¼ö 0
÷ºÎÆÄÀÏ
¸Þ´º´Ý±â

°ßÀû¹®ÀÇ

INQUIRY

¾Æ·¡ Ç׸ñ¿¡ ¸Â°Ô Á¤È®È÷ ÀÔ·ÂÇÏ¿© ÁֽʽÿÀ.